Physician profile
Vafa Shayani
NPI 1134193220
$20,933.68
in general payments reported to CMS, 2019-2025
17 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,648 · 2021: $486 · 2022: $3,704 · 2023: $1,055 · 2024: $1,668 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,813 · Food and Beverage: $1,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,812.50 |
| Food and Beverage | $1,502.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspire Bariatrics, INC. | $13,768.56 | 2019-2022 | |
| Reshape Lifesciences INC. | $2,965.11 | 2019-2024 | |
| Medtronic, INC. | $855.79 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $697.89 | 2019-2024 | Seamguard Staple Line Reinforcement |
| Stryker Corporation | $500.00 | 2025 | |
| Teleflex LLC | $421.94 | 2023-2025 | Titan Sgs Standard Gastric Stapler, Titan Sgs, Titan Sgs Bailout Chuck |
| Ethicon US, LLC | $348.14 | 2020-2024 | Echelon Flex, Megadyne, Enseal X1 |
| Covidien LP | $304.00 | 2020 | |
| Enterra Medical, INC. | $277.04 | 2023 | |
| Endogastric Solutions, INC | $221.84 | 2023-2024 | Esophyx |
| Baxter Healthcare | $189.50 | 2019-2025 | Tisseel |
| Rhythm Pharmaceuticals, INC. | $104.01 | 2021 | |
| Standard Bariatrics, INC. | $85.27 | 2022 | |
| Apollo Endosurgery US INC | $65.84 | 2019 | |
| Bard Peripheral Vascular, INC. | $58.04 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apyx Medical Corporation | $37.39 | 2020 | |
| Novo Nordisk INC | $33.32 | 2023-2024 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vafa Shayani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.